Systemic lupus erythematosus (lupus) disproportionately affects women, racial/ethnic minorities and low-income populations. We held focus groups for women from medically underserved communities to discuss interventions to improve care.
Methods
From our Lupus Registry, we invited 282 women, ≥18 years, residing in urban, medically underserved areas. Hospital-based clinics and support groups also recruited participants. Women were randomly assigned to three focus groups. Seventy-five-minute sessions were recorded, transcribed and coded thematically using interpretative phenomenologic analysis and single counting methods. We categorized interventions by benefits, limitations, target populations and implementation questions.
Results
Twenty-nine women with lupus participated in three focus groups, (n = 9, 9, 11). 80% were African American and 83% were from medically underserved zip codes. Themes included the desire for lupus education, isolation at the time of diagnosis, emotional and physical barriers to care, and the need for assistance navigating the healthcare system. Twenty of 29 participants (69%) favored a peer support intervention; 17 (59%) also supported a lupus health passport. Newly diagnosed women were optimal intervention targets. Improvements in quality of life and mental health were proposed outcome measures.
Conclusion
Women with lupus from medically underserved areas have unique needs best addressed with an intervention designed through collaboration between community members and researchers.
FesselWJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med1974; 134: 1027–1035.
2.
FernandezMAlarconGSCalvo-AlenJ. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum2007; 57: 576–584.
3.
GillisJZYazdanyJTrupinL. Medicaid and access to care among persons with systemic lupus erythematosus. Arthritis Rheum2007; 57: 601–607.
4.
YazdanyJGillisJZTrupinL. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum2007; 57: 593–600.
5.
BaeSCHashimotoHKarlsonEW. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol2001; 28: 1245–1251.
6.
OwMYHoPCThumbooJ. Factors associated with health services utilization in patients with systemic lupus erythematosus: a systematic review. Clin Exp Rheumatol2010; 28: 892–904.
7.
OdutolaJWardMM. Ethnic and socioeconomic disparities in health among patients with rheumatic disease. Curr Opin Rheumatol2005; 17: 147–152.
8.
CampbellRJrCooperGSGilkesonGS. Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. Arthritis Rheum2008; 59: 458–464.
9.
Pons-EstelGJAlarconGSScofieldL. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39: 257–268.
10.
AndrulisDP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med1998; 129: 412–416.
11.
ZuvekasSHTaliaferroGS. Pathways to access: health insurance, the health care delivery system, and racial/ethnic disparities, 1996–1999. Health Aff (Millwood)2003; 22: 139–153.
12.
SteinbergMLFremontAKhanDC. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer2006; 107: 2669–2677.
13.
LebwohlBNeugutAIStavskyE. Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol2011; 45: e47–e53.
14.
RobieLAlexandruDBotaDA. The use of patient navigators to improve cancer care for Hispanic patients. Clin Med Insights Oncol2011; 5: 1–7.
15.
Philis-TsimikasAFortmannALleva-OcanaL. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial. Diabetes Care2011; 34: 1926–1931.
16.
WuCJChangAMCourtneyM. Development and pilot test of a peer-support based Cardiac-Diabetes Self-Management Program: a study protocol. BMC Health Serv Res2011; 11: 74–74.
17.
HaideriNAMoormeierJA. Impact of patient navigation from diagnosis to treatment in an urban safety net breast cancer population. J Cancer2011; 2: 467–473.
18.
DijkstraRFBraspenningJCHuijsmansZ. Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care. Diabetes Res Clin Pract2005; 68: 126–134.
19.
DijkstraRBraspenningJGrolR. Empowering patients: how to implement a diabetes passport in hospital care. Patient Educ Couns2002; 47: 173–177.
20.
VaczyESeamanBPeterson-SweeneyK. Passport to health: an innovative tool to enhance healthy lifestyle choices. J Pediatr Health Care2011; 25: 31–37.
21.
SimmonsDGambleGDFooteS. The New Zealand Diabetes Passport Study: a randomized controlled trial of the impact of a diabetes passport on risk factors for diabetes-related complications. Diabet Med2004; 21: 214–217.
22.
CookNLAyanianJZOravEJ. Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care. Circulation2009; 119: 2463–2470.
23.
KarlsonEWDaltroyLHLewRA. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum1997; 40: 47–56.
24.
KarlsonEWLiangMHEatonH. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum2004; 50: 1832–1841.
25.
BanduraA. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev1977; 84: 191–215.
26.
HortonRPetersonMGPowellS. Users evaluate LupusLine, a telephone peer counseling service. Arthritis Care Res1997; 10: 257–263.
27.
Fortin P. Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus. 2010, http://www.uhnres.utoronto.ca/tdc/documents/LupusHealthPassport.pdf.
28.
HRSA. Medically Underserved Areas & Populations (MUA/Ps). 2011, http://muafind.hrsa.gov/.
29.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
30.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
31.
HaleEDTreharneGJLyonsAC. “Joining the dots” for patients with systemic lupus erythematosus: personal perspectives of health care from a qualitative study. Ann Rheum Dis2006; 65: 585–589.
32.
PringleJDrummondJMcLaffertyE. Interpretative phenomenological analysis: a discussion and critique. Nurse Res2011; 18: 20–24.
33.
McParlandJLEcclestonCOsbornM. It's not fair: an Interpretative Phenomenological Analysis of discourses of justice and fairness in chronic pain. Health (London)2011; 15: 459–474.
34.
PollardLCGravesHScottDL. Perceived barriers to integrated care in rheumatoid arthritis: views of recipients and providers of care in an inner-city setting. BMC Musculoskelet Disord2011; 12: 19–19.
35.
LemppHKHatchSLCarvilleSF. Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study. BMC Musculoskelet Disord2009; 10: 124–124.
36.
SealeC (eds), The quality of qualitative research, London: Sage Publications, 1999.
37.
James BD, Boyle PA, Bennett JS, et al. The impact of health and financial literacy on decision making in community-based older adults. Gerontology 2012; 58: 531–539.
38.
MurphyLBSacksJJBradyTJ. Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res2012; 64: 968–976.
39.
MoussaviSChatterjiSVerdesE. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet2007; 370: 851–858.
40.
Garay-SevillaMEMalacaraJMGutierrez-RoaA. Denial of disease in type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabet Med1999; 16: 238–244.
41.
AnthonyHValinskyLInbarZ. Perceptions of hypertension treatment among patients with and without diabetes. BMC Fam Pract2012; 13: 24–24.
42.
KaltsoudaASkapinakisPDamigosD. Defensive coping and health-related quality of life in chronic kidney disease: a cross-sectional study. BMC Nephrol2011; 12: 28–28.
43.
WaldronNBrownSHewlettS. ‘It's more scary not to know': a qualitative study exploring the information needs of patients with systemic lupus erythematosus at the time of diagnosis. Musculoskeletal Care2011; 9: 228–238.
44.
IsraelBASchulzAJParkerEA. Community-based participatory research: policy recommendations for promoting a partnership approach in health research. Educ Health (Abingdon)2001; 14: 182–197.
45.
LantzPMViruell-FuentesEIsraelBA. Can communities and academia work together on public health research? Evaluation results from a community-based participatory research partnership in Detroit. J Urban Health2001; 78: 495–507.
46.
KarlsonEWWattsJSignorovitchJ. Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project. Arthritis Rheum2007; 56: 244–254.
